22 April 2020 Gilead, Kite pen natural killer pact with little-known Australian cell therapy player Read More
22 April 2020 Amid remdesivir craze Gilead finds time for another oncology pact — looping in all things NK cells Read More
17 March 2020 You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy Read More
21 August 2019 Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response Read More
30 July 2019 A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients Read More
12 May 2019 Quantifying NK cell growth and survival changes in response to cytokines and regulatory checkpoint blockade helps identify optimal culture and expansion conditions Read More
